Untether AI, a company that has developed an AI chip that can transfer data 1000 times faster than the conventional chip, has announced a $20 million Series A. The company has also appointed technology veteran Arun Iyengar as CEO.
Healx, a startup that uses artificial intelligence to quickly identify and develop treatments for rare diseases, raises a $56 million Series B to support its clinical trials and launch of its global Rare Treatment Accelerator program.
IOTAS, a startup that helps landlords install and manage smart home devices, announces a Series A investment of $8.5 million to scale its operations and invest in software to support utility and internet providers.
DustPhotonics, a provider of optical modules for enabling data center and high-performance computing connectivity, announces a Series B investment of $25M led by Intel Capital, with participation by WRVI Capital and veteran entrepreneur Avigdor Willenz.
Bromium uses virtualization technology to stop attacks in real-time. Its acquisition by HP will integrate Bromium’s technology into its security security platform and hardware.
DataRobot, which sells software that helps companies develop and deploy in-house AI models, raises a $206 million Series E to contribute to the continued development of their AI platform.
Our portfolio company Arcadia Data, a provider of cloud-native AI-powered business intelligence and real-time analytics, has entered into an agreement to be acquired by Cloudera, an enterprise data cloud company, for an undisclosed amount.
At Hot Chips 2019, optical I/O technology startup Ayar Labs collaborated with Intel to demonstrate the industry’s first integration of Monolithic In-Package Optics with a high-performance System-On-a-Chip. This partnership will help enable new approaches to architecting computing systems for the next phase of Moore’s Law.
Mech-Mind, a company that deploys smart solutions leveraging 3D-vision and artificial intelligence for robotics, has announced new funding from Intel to continue expanding in international markets.
VeriSIM Life, a company that builds digital simulations to avoid human and animal drug testing, has raised $5.2 million in funding.